Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Cassidy J.,,Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: A meta-analysis of individual data from 6171 patients,2011,Annals of Oncology,64,10.1093/annonc/mdr031,United Kingdom,Article,Glasgow,1,Journal,2-s2.0-80052529758
Kim K.,,Evaluation of HER2 protein expression in gastric carcinomas: Comparative analysis of 1414 cases of whole-tissue sections and 595 cases of tissue microarrays,2011,Annals of Surgical Oncology,109,10.1245/s10434-011-1695-2,South Korea,Article,Ulsan,0,Journal,2-s2.0-80052697178
Wang W.,,Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection-results of a singleinstitution study of 1343 Chinese patients,2011,Annals of Oncology,69,10.1093/annonc/mdq716,China,Article,Guangzhou,1,Journal,2-s2.0-80052422756
Chae S.,,The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: A comparative study between the 5th/6th and 7th UICC N classification,2011,Gastric Cancer,72,10.1007/s10120-011-0024-6,South Korea,Article,Seoul,1,Journal,2-s2.0-79959373708
Mocellin S.,,EUS for the staging of gastric cancer: A meta-analysis,2011,Gastrointestinal Endoscopy,85,10.1016/j.gie.2011.01.030,Italy,Article,Padua,0,Journal,2-s2.0-79957803200
Tramacere I.,,Tobacco smoking and esophageal and gastric cardia adenocarcinoma: A meta-analysis,2011,Epidemiology,67,10.1097/EDE.0b013e31821092cd,Italy,Article,Milan,0,Journal,2-s2.0-79955066348
González C.,,Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: A long-term follow-up in a high-risk area in Spain,2011,American Journal of Gastroenterology,87,10.1038/ajg.2011.1,Portugal,Article,Porto,0,Journal,2-s2.0-79955601017
Islami F.,,Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma-a systematic review and meta-analysis,2011,Annals of Oncology,42,10.1093/annonc/mdq411,Iran;France;United Kingdom,Review,Tehran;Lyon;London,1,Journal,2-s2.0-79953306837
Kim H.,,"Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas",2011,Experimental and Molecular Pathology,16,10.1016/j.yexmp.2010.12.004,South Korea,Article,Seoul,0,Journal,2-s2.0-78651259870
Grávalos C.,,Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer,2011,Clinical and Translational Oncology,61,10.1007/s12094-011-0637-6,Spain,Article,Madrid,0,Journal,2-s2.0-79958202400
Wang J.,,Gastric atrophy and intestinal metaplasia before and after helicobacter pylori eradication: A Meta-analysis,2011,Digestion,130,10.1159/000280318,China;China,Article,Nanjing;Yancheng,0,Journal,2-s2.0-79251592276
Zhu Y.,,The association between interleukin-10-592 polymorphism and gastric cancer risk: A meta-analysis,2011,Medical Oncology,12,10.1007/s12032-010-9417-3,China,Article,Hefei,0,Journal,2-s2.0-79952245450
Barros R.,,CDX2 autoregulation in human intestinal metaplasia of the stomach: Impact on the stability of the phenotype,2011,Gut,40,10.1136/gut.2010.222323,Portugal,Article,Porto,1,Journal,2-s2.0-79851514659
Montagnani F.,,"Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: A systematic review and meta-analysis",2011,Gastric Cancer,87,10.1007/s10120-011-0007-7,Italy,Article,Florence,1,Journal,2-s2.0-79953027573
Cavaleiro-Pinto M.,,Helicobacter pylori infection and gastric cardia cancer: Systematic review and meta-analysis,2011,Cancer Causes and Control,104,10.1007/s10552-010-9707-2,Portugal,Article,Porto,0,Journal,2-s2.0-79955782286
Persson C.,,Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses,2011,American Journal of Epidemiology,146,10.1093/aje/kwq370,United States;Sweden,Article,Bethesda;Stockholm,1,Journal,2-s2.0-79251525848
Wu S.,,Fish consumption and the risk of gastric cancer: Systematic review and meta-analysis,2011,BMC Cancer,27,10.1186/1471-2407-11-26,China,Article,Xi'an,1,Journal,2-s2.0-78651532400
Peleteiro B.,,"Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type",2011,British Journal of Cancer,71,10.1038/sj.bjc.6605993,Portugal,Article,Porto,1,Journal,2-s2.0-78650904591
Gobbi P.G.,,Improving the AJCC/TNM Classification for Use in Early Gastric Cancer,2011,Journal of Gastrointestinal Surgery,5,10.1007/s11605-011-1522-x,Italy,Article,Pavia,0,Journal,2-s2.0-79955864972
Rothwell P.M.,,Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials,2011,The Lancet,1028,10.1016/S0140-6736(10)62110-1,United Kingdom,Article,Oxford,0,Journal,2-s2.0-78650825618
Ahn H.S.,,Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification,2010,Cancer,163,10.1002/cncr.25550,South Korea,Article,Seoul,0,Journal,2-s2.0-78650115024
Wang D.,,Irinotecan-involved regimens for advanced gastric cancer: A pooled-analysis of clinical trials,2010,World Journal of Gastroenterology,8,10.3748/wjg.v16.i46.5889,China;China,Article,Nanjing;Nanjing,1,Journal,2-s2.0-78650620190
Schuhmacher C.,,Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European organisation for research and treatment of cancer randomized trial 40954,2010,Journal of Clinical Oncology,414,10.1200/JCO.2009.26.6114,,Article,,0,Journal,2-s2.0-79951904022
Xu W.,,Association between EGF promoter polymorphisms and cancer risk: A meta-analysis,2010,Medical Oncology,21,10.1007/s12032-009-9392-8,China,Article,Nanjing,0,Journal,2-s2.0-78650036984
Imagawa S.,,Helicobacter pylori dupA and gastric acid secretion are negatively associated with gastric cancer development,2010,Journal of Medical Microbiology,21,10.1099/jmm.0.021816-0,Japan,Article,Higashihiroshima,1,Journal,2-s2.0-78649423785
Okubo M.,,Association Between Common Genetic Variants in Pre-microRNAs and Gastric Cancer Risk in Japanese Population,2010,Helicobacter,150,10.1111/j.1523-5378.2010.00806.x,Japan,Article,Toyoake,0,Journal,2-s2.0-78349278399
Li W.,,Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis,2010,World Journal of Gastroenterology,73,10.3748/wjg.v16.i44.5621,China,Article,Shanghai,1,Journal,2-s2.0-78649715222
Bornschein J.,,H. pylori infection is a key risk factor for proximal gastric cancer,2010,Digestive Diseases and Sciences,52,10.1007/s10620-010-1351-x,Germany,Article,Magdeburg,0,Journal,2-s2.0-78149360152
Mizuno S.,,Prescreening of a high-risk group for gastric cancer by serologically determined helicobacter pylori infection and atrophic gastritis,2010,Digestive Diseases and Sciences,77,10.1007/s10620-010-1154-0,Japan,Article,Kobe,0,Journal,2-s2.0-78149358080
Tsang Y.,,Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation,2010,Oncogene,69,10.1038/onc.2010.304,United States;Singapore,Article,Chicago;Singapore City,1,Journal,2-s2.0-77958016084
Zhou Y.,,"Vascular endothelial growth factor (VEGF) +936 C/T gene polymorphisms and gastric cancer risk: A meta-analysis involving 4,138 subjects",2010,International Journal of Biological Markers,9,10.5301/JBM.2010.6110,China,Article,Chengdu,0,Journal,2-s2.0-78650821377
Tucker T.,,Helicobacter pylori induction of the gastrin promoter through GC-rich DNA elements,2010,Helicobacter,10,10.1111/j.1523-5378.2010.00787.x,United States,Article,Ann Arbor,0,Journal,2-s2.0-77956517223
André A.,,Gastric adenocarcinoma and Helicobacter pylori: Correlation with p53 mutation and p27 immunoexpression,2010,Cancer Epidemiology,14,10.1016/j.canep.2010.05.005,Brazil,Article,Fortaleza,0,Journal,2-s2.0-77957236203
Wijetunge S.,,"Association of adenocarcinomas of the distal esophagus, ""gastroesophageal junction,"" and ""gastric cardia"" with gastric pathology",2010,American Journal of Surgical Pathology,20,10.1097/PAS.0b013e3181eff133,Sri Lanka;United States,Article,Kandy;Los Angeles,0,Journal,2-s2.0-77957908866
Lombardo L.,,Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test,2010,Clinical Chemistry and Laboratory Medicine,16,10.1515/CCLM.2010.256,Italy,Article,Turin,0,Journal,2-s2.0-77957306893
Moy K.A.,,"Alcohol and tobacco use in relation to gastric cancer: A prospective study of men in Shanghai, China",2010,Cancer Epidemiology Biomarkers and Prevention,63,10.1158/1055-9965.EPI-10-0362,United States;United States,Article,Minneapolis;Minneapolis,1,Journal,2-s2.0-77956519055
Rokkas T.,,Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: A meta-analysis,2010,European Journal of Gastroenterology and Hepatology,65,10.1097/MEG.0b013e3283398d37,Greece,Article,Athens,0,Journal,2-s2.0-77955466167
Soerjomataram I.,,Increased consumption of fruit and vegetables and future cancer incidence in selected European countries,2010,European Journal of Cancer,78,10.1016/j.ejca.2010.07.026,Netherlands;Netherlands,Article,Rotterdam;Eindhoven,0,Journal,2-s2.0-77956623051
Bang Y.J.,,"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial",2010,The Lancet,4004,10.1016/S0140-6736(10)61121-X,South Korea,Article,Seoul,0,Journal,2-s2.0-77956262693
Zhao C.,,Involvement of tumor necrosis factor-α in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori,2010,BMC Cancer,35,10.1186/1471-2407-10-419,China,Article,Shenyang,1,Journal,2-s2.0-77955360972
Chung W.C.,,The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer,2010,Gastric Cancer,9,10.1007/s10120-010-0552-5,South Korea,Article,Youngdeungpo,1,Journal,2-s2.0-77957963054
Yin F.,,"Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: Links to soluble HB-EGF, gastrin and matrix metalloproteinase-7",2010,Gut,71,10.1136/gut.2009.199794,United Kingdom,Article,Nottingham,1,Journal,2-s2.0-77954691423
Qiu H.,,Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer,2010,BMC Cancer,45,10.1186/1471-2407-10-374,China,Article,Guangzhou,1,Journal,2-s2.0-77954545365
Hussein N.,,The association of dupA and Helicobacter pylori-related gastroduodenal diseases,2010,European Journal of Clinical Microbiology and Infectious Diseases,41,10.1007/s10096-010-0933-z,United Kingdom,Article,Nottingham,0,Journal,2-s2.0-77955431493
Tian W.,,Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer,2010,European Journal of Cancer Prevention,56,10.1097/CEJ.0b013e328339648c,China,Article,Harbin,0,Journal,2-s2.0-77953538362
Zhang X.,,"SOX2 in gastric carcinoma, but not hath1, is related to patients' clinicopathological features and prognosis",2010,Journal of Gastrointestinal Surgery,49,10.1007/s11605-010-1246-3,China,Article,Chongqing,0,Journal,2-s2.0-77954953153
Jeong C.W.,,Mitochondrial microsatellite instability in gastric cancer and gastric epithelial dysplasia as a precancerous lesion,2010,Cancer Epidemiology,18,10.1016/j.canep.2010.03.015,South Korea,Article,Dalseo-gu,0,Journal,2-s2.0-77952242686
Yang P.,,Aspirin use and the risk of gastric cancer: A meta-analysis,2010,Digestive Diseases and Sciences,47,10.1007/s10620-009-0915-0,China,Review,Chengdu,0,Journal,2-s2.0-77954427051
Yeh Y.,,Elevated serum matrix metalloproteinase-3 and -7 in H. Pylori-related gastric cancer can be biomarkers correlating with a poor survival,2010,Digestive Diseases and Sciences,52,10.1007/s10620-009-0926-x,Taiwan,Article,Tainan,0,Journal,2-s2.0-77954424331
Huerta J.M.,,Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European prospective investigation into cancer and nutrition) cohort,2010,Cancer Causes and Control,45,10.1007/s10552-009-9493-x,Spain;Spain;Spain,Article,Barcelona;Murcia;Murcia,0,Journal,2-s2.0-77955297532
Partida-Rodríguez O.,,Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer,2010,International Journal of Cancer,51,10.1002/ijc.24773,Mexico,Article,Mexico City,0,Journal,2-s2.0-77949897859
Gonázlez C.,,"Helicobacter pylori, nutrition and smoking interactions: Their impact in gastric carcinogenesis",2010,Scandinavian Journal of Gastroenterology,47,10.3109/00365520903401959,Spain,Review,Barcelona,0,Journal,2-s2.0-73649090360
Norman G.,,Capecitabine for the treatment of advanced gastric cancer.,2010,"Health technology assessment (Winchester, England)",10,10.3310/hta14suppl2/02,United Kingdom,Review,York,1,Journal,2-s2.0-84886943116
Yeh J.,,Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival,2010,Gastrointestinal Endoscopy,12,10.1016/j.gie.2010.01.047,United States,Article,Boston,0,Journal,2-s2.0-77954063830
Kim J.H.,,Effect of Helicobacter pylori infection on the sonic hedgehog signaling pathway in gastric cancer cells,2010,Oncology Reports,18,10.3892/or-00000791,South Korea,Article,Seoul,0,Journal,2-s2.0-77951749929
Hassan C.,,Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia,2010,Helicobacter,32,10.1111/j.1523-5378.2010.00752.x,Italy,Article,Rome,0,Journal,2-s2.0-77952128298
Hanaoka N.,,Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication,2010,Journal of Gastroenterology and Hepatology (Australia),40,10.1111/j.1440-1746.2010.06442.x,Japan,Article,Kurashiki,0,Journal,2-s2.0-78649539985
Nguyen L.T.,,Helicobacter pylori dupA gene is not associated with clinical outcomes in the Japanese population,2010,Clinical Microbiology and Infection,43,10.1111/j.1469-0691.2009.03081.x,Japan,Article,Yufu,1,Journal,2-s2.0-77955153718
De Vries A.,,Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions,2010,Helicobacter,52,10.1111/j.1523-5378.2010.00760.x,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-77954830899
Nakajima S.,,Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years,2010,Journal of Gastroenterology and Hepatology (Australia),56,10.1111/j.1440-1746.2009.06214.x,Japan,Conference Paper,Otsu,0,Journal,2-s2.0-77951519480
Xue H.,,Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: A meta-analysis,2010,Journal of Gastroenterology and Hepatology (Australia),94,10.1111/j.1440-1746.2010.06428.x,China,Article,Shanghai,1,Journal,2-s2.0-77957579928
Wei J.,,Regulation of p53 tumor suppressor by helicobacter pylori in gastric epithelial cells,2010,Gastroenterology,97,10.1053/j.gastro.2010.06.018,United States,Article,Nashville,0,Journal,2-s2.0-77957353073
Peterson A.,,"Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans",2010,Gastroenterology,110,10.1053/j.gastro.2010.08.043,Australia,Article,Melbourne,0,Journal,2-s2.0-78649706953
Rugge M.,,Gastritis OLGA-staging and gastric cancer risk: A twelve-year clinico-pathological follow-up study,2010,Alimentary Pharmacology and Therapeutics,169,10.1111/j.1365-2036.2010.04277.x,Italy;Italy,Article,Padova;Padua,1,Journal,2-s2.0-77951239904
Rugge M.,,Gastritis staging in clinical practice: The OLGA staging system,2007,Gut,263,10.1136/gut.2006.106666,Italy,Article,Padua,0,Journal,2-s2.0-34247509658
